Wednesday, August 20, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipating EverQuotes Quarterly Earnings Analysts Predict 032 EPS

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Tech-banking-finance
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

EverQuote (NASDAQ: EVER) is set to announce its quarterly earnings on February 26, 2024. Analysts are predicting an EPS of $-0.32 for the company.

– Analysts are estimating an EPS of $-0.32.
– Last quarter, EverQuote missed EPS by $0.27, leading to a 16.94% increase in share price the following day.
– EverQuote’s stock was trading at $16.51 on February 22, marking a 5.48% decrease over the past year.

Investors are hopeful that EverQuote will surpass the expected EPS and offer positive guidance for future growth, potentially boosting the stock price. It’s worth noting that guidance can have a greater impact on stock movement than beating or missing earnings estimates.

EverQuote Inc. (EVER) Stock Shows Strong Performance on February 23, 2024

On February 23, 2024, EverQuote Inc. (EVER) showed strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, EVER demonstrated positive price momentum.

The price of EVER shares increased by $0.18 since the market last closed, representing a 1.09% rise. The stock opened at $16.67, $0.16 higher than its previous close, indicating a strong start to the trading day.

EVER Stock Performance Declines on February 23, 2024: Financial Data Analysis

On February 23, 2024, EVER stock experienced a decline in performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $404.13 million, which decreased by 3.44% compared to the previous year. In the most recent quarter, the total revenue was $55.01 million, showing a significant decrease of 19.08% since the last quarter.

The net income for EVER over the past year was -$24.42 million, indicating a decrease of 25.64% from the previous year. In the third quarter of the fiscal year, the net income was -$29.22 million, which represents a substantial decline of 121.46% compared to the last quarter.

Furthermore, the earnings per share (EPS) for EVER were -$0.77 for the past year, reflecting a decrease of 15.6% since the previous year. In the third quarter, the EPS was -$0.87, showing a significant drop of 118.71% since the last quarter.

Overall, the financial performance of EVER on February 23, 2024, was disappointing, with decreases in total revenue, net income, and earnings per share compared to both the previous year and the last quarter. Investors and analysts may need to closely monitor the company’s financial health and strategic decisions to assess its future prospects and potential for growth.

Tags: EVER
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Oil and Gas Producers Stock Market Today

Anticipating DrilQuips Earnings Performance A Look at Past Results and Market Expectations

Healthcare-and-IT

Analyst Ratings and Price Targets for Evolent Health Recent Updates and Insights

Finance_Assets

Analysts Offer Differing Price Targets for Amgen NASDAQ AMGN

Recommended

MMM stock news

Analyst Downgrades 89bio Rating and Sets 15 Price Target

2 years ago

Exelon Receives Upgrade and Potential for Significant Growth

2 years ago
Insurance company Markets and money

Title NI Holdings Reports Impressive Financial Results for Q4 2023

1 year ago
Eli Lilly Stock

Eli Lilly Stock: Trump’s Mixed Signals Shake Pharma Giant

3 weeks ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NIO NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

PLDT’s Strategic Pivot: Strong Earnings Overshadowed by Data Center Venture

Leadership Shakeup Halts Opendoor’s Stock Rally

Oracle’s Strategic Pivot: Workforce Reductions Fuel Aggressive AI Investment

UnitedHealth Investment by Berkshire Sparks Initial Rally, But Concerns Linger

Appian Unveils Strategic AI Platform Enhancements for Enterprise Automation

Institutional Confidence Grows for Inspire Medical Amid Mixed Analyst Sentiment

Trending

Red Cat Stock
Stocks

Defense Sector Breakthrough Positions Red Cat for Major Growth

by Dieter Jaworski
August 20, 2025
0

Red Cat Holdings has achieved a critical strategic milestone that solidifies its standing within the lucrative defense...

VanEck Gaming ETF Stock

VanEck’s Gaming ETF Surges 37% in 2025, But Is a Correction Underway?

August 20, 2025
Regenxbio Stock

Regenxbio Shares Slide as FDA Pushes Back Key Drug Decision

August 20, 2025
Pldt Inc Stock

PLDT’s Strategic Pivot: Strong Earnings Overshadowed by Data Center Venture

August 20, 2025
Opendoor Stock

Leadership Shakeup Halts Opendoor’s Stock Rally

August 20, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Defense Sector Breakthrough Positions Red Cat for Major Growth August 20, 2025
  • VanEck’s Gaming ETF Surges 37% in 2025, But Is a Correction Underway? August 20, 2025
  • Regenxbio Shares Slide as FDA Pushes Back Key Drug Decision August 20, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com